Related Experiment Video
Updated: Aug 23, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
Published on: October 6, 2023
Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases
Xiteng Chen1, Yuanfeng Jiang1, Yanan Duan1
1Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China.
Abstract:
Retinal diseases are major causes of irreversible vision loss and blindness. Despite extensive research into their pathophysiology and etiology, pharmacotherapy effectiveness and surgical outcomes remain poor. Based largely on numerous preclinical studies, administration of mesenchymal stem cells (MSCs) as a therapeutic strategy for retinal diseases holds great promise, and various approaches have been applied to the therapies. However, hindered by the retinal barriers, the initial vision for the stem cell replacement strategy fails to achieve the anticipated effect and has now been questioned. Accumulating evidence now suggests that the paracrine effect may play a dominant role in MSC-based treatment, and MSC-derived extracellular vesicles emerge as a novel compelling alternative for cell-free therapy. This review summarizes the therapeutic potential and current strategies of this fascinating class of cells in retinal degeneration and other retinal dysfunctions.
Insights
Mesenchymal stem cells (MSCs) show promise for retinal diseases. MSC-derived extracellular vesicles offer a cell-free therapy alternative, overcoming limitations of direct cell transplantation for vision restoration.
Area of Science:
- Ophthalmology and Regenerative Medicine
Background:
- Retinal diseases cause irreversible vision loss, with limited treatment success.
- Mesenchymal stem cells (MSCs) are investigated for retinal disease therapy.
- Direct MSC transplantation faces challenges due to retinal barriers.
Purpose of the Study:
- To review the therapeutic potential of MSCs and MSC-derived extracellular vesicles for retinal diseases.
- To summarize current strategies for utilizing these cell-based and cell-free approaches.
Main Methods:
- Review of preclinical studies on MSC therapy for retinal degeneration.
- Analysis of the role of paracrine effects in MSC-based treatments.
- Evaluation of MSC-derived extracellular vesicles as a cell-free therapeutic alternative.
Main Results:
- Direct MSC transplantation efficacy is limited by retinal barriers.
- The paracrine effect of MSCs is a key mechanism in treatment.
- MSC-derived extracellular vesicles present a promising cell-free therapeutic strategy.
Conclusions:
- MSC-derived extracellular vesicles offer a novel and effective cell-free therapeutic approach for retinal diseases.
- This strategy bypasses the limitations of direct cell transplantation, holding potential for vision restoration.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells

